Tempus AI (NASDAQ:TEM) Downgraded to Hold Rating by Stifel Nicolaus

Stifel Nicolaus lowered shares of Tempus AI (NASDAQ:TEM) from a buy rating to a hold rating in a report released on Monday morning, Marketbeat reports. They currently have $65.00 target price on the stock, up from their previous target price of $45.00.

A number of other research analysts have also weighed in on TEM. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and lifted their price target for the company from $45.00 to $60.00 in a research note on Wednesday, October 2nd. JPMorgan Chase & Co. boosted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Loop Capital boosted their price objective on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research report on Tuesday, October 15th. Needham & Company LLC reissued a “buy” rating and issued a $47.00 price objective on shares of Tempus AI in a research report on Wednesday, August 7th. Finally, Piper Sandler assumed coverage on shares of Tempus AI in a research report on Monday, August 12th. They set a “neutral” rating and a $40.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Tempus AI presently has an average rating of “Moderate Buy” and a consensus price target of $50.89.

Tempus AI Stock Performance

Shares of NASDAQ TEM opened at $77.62 on Monday. The firm’s 50 day moving average price is $50.58. The company has a quick ratio of 3.52, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI has a 52-week low of $22.89 and a 52-week high of $78.00.

Hedge Funds Weigh In On Tempus AI

Several institutional investors and hedge funds have recently modified their holdings of TEM. EFG Asset Management North America Corp. acquired a new position in shares of Tempus AI in the second quarter valued at about $1,333,000. ARK Investment Management LLC acquired a new stake in Tempus AI during the second quarter worth about $18,294,000. Northwestern University acquired a new stake in Tempus AI during the second quarter worth about $491,000. Alphabet Inc. acquired a new stake in Tempus AI during the second quarter worth about $54,289,000. Finally, Pier Capital LLC acquired a new stake in Tempus AI during the second quarter worth about $2,301,000.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.